This episode of “WisBusiness: The Podcast” features Chorom Pak, founder of Lynx Biosciences, who tells how the company’s “functional companion diagnostics” can help determine the efficacy of blood cancer treatments.

She also talks about completing a recent retrospective clinical trial, and gives an update on the company’s progress toward commercialization. Listen to the podcast here.